NUREMBERG, Germany, March 10, 2026, 15:14 CET
Intel rolled out a fresh batch of processors aimed at industrial gear and medical devices during Embedded World in Nuremberg on Tuesday, doubling down on edge AI under Chief Executive Lip-Bu Tan’s leadership as he works to turn the U.S. chipmaker around. The chips are already shipping in systems, Intel noted, and a related healthcare software suite will see a broader rollout in the second quarter. Newsroom
This is a big deal for Intel, which is under pressure to prove it can deliver commercial chips on schedule and tap into AI demand beyond the pricier data-center segment dominated by Nvidia. The announcement lands just two months after Intel showed off Panther Lake—its initial PC chip designed with the 18A manufacturing process, a significant next step for the company. Reuters
This comes just days after finance chief David Zinsner revealed that Tan was weighing whether to keep 18A mostly in-house or start offering it to external foundry clients, now that yields are picking up. Last week, Intel said board chair Frank Yeary will retire in May, making way for longtime semiconductor executive Craig Barratt—Tan’s overhaul now stretches from production lines up to the boardroom. Reuters
Intel is pitching its Core Series 2 chips as tailor-made for mission-critical edge systems—think hardware where consistent response matters more than raw speed. Factory machines and medical devices, for example, can use the new processors to juggle control software alongside AI workloads without risking delays or glitches. Newsroom
Dan Rodriguez, who leads Intel’s edge computing division, called edge “one of our fastest-growing business segments.” He said Intel aims to expand its hardware and software lineup for customers deploying AI at the data source, rather than routing everything to distant cloud servers. Newsroom
Intel also pulled back the curtain on its Edge AI Suite for Health & Life Sciences, rolling out reference tools aimed at tasks like ECG arrhythmia detection, tracking pulses via video, and running anonymous 3D motion analysis. A preview version is already live on GitHub, Intel said, with a wider release targeted for the second quarter. Intel® Industry Solution Builders
Intel took the opportunity to take aim at AMD, claiming in its own testing that the new chips outperform AMD’s Ryzen 7 9700X on various latency and response-time metrics. It’s a pointed move: Intel has been losing PC market share to AMD and, on the manufacturing front, has seen Taiwan Semiconductor Manufacturing Co. gain ground over the years. Newsroom
Intel climbed roughly 1.6% during Tuesday’s morning session in the U.S. The name’s been volatile, with investors weighing Tan’s aggressive cost-cutting and next-gen product rollouts against a turnaround that’s far from complete. Back in January, Gabelli Funds analyst Ryuta Makino observed that sentiment for Intel was the strongest it had been in years. Reuters
The latest edge rollout doesn’t resolve Intel’s broader execution problems. Back in January, the company acknowledged difficulty keeping up with demand for server CPUs paired with AI chips. Tan noted 18A yields are getting better, but not quite meeting his targets yet. Running Point Capital’s Michael Schulman described Intel’s turnaround as “supply-constrained rather than demand-constrained.” Also last week, U.S. lawmakers flagged national security issues regarding Intel’s testing of China-linked ACM Research tools; Intel responded, saying those tools aren’t part of its production lines and that it follows U.S. law. Reuters
